Odland Hans Henrik, Thaulow Erik M D
Barneklinikken, Rikshospitalet, 0027 Oslo, Norway.
Expert Rev Cardiovasc Ther. 2006 Jan;4(1):33-40. doi: 10.1586/14779072.4.1.33.
The most common reason for heart failure in children is volume overload secondary to a left-to-right shunt. Therefore, an accurate diagnosis with identification of possible surgical or interventional reactions should be the first priority. Medical therapy is mainly based on diuretics, angiotensin-converting enzyme inhibitors, cardiac glycosides and beta-blockers. There are few prospective trials in pediatric cardiology, but the available data reach a similar conclusion to that of adults with heart failure. Diuretics are an important tool in patients with fluid retention, and angiotensin-converting enzyme inhibitors are helpful in patients with volume overload of the ventricles. Cardiac glycosides are still in use, but there is a trend toward primary use of diuretics. Angiotensin-converting enzyme inhibitors and beta-blockers have been used successfully in the treatment of heart failure in children, but there are limited data on its efficacy.
儿童心力衰竭最常见的原因是继发于左向右分流的容量负荷过重。因此,准确诊断并确定可能的手术或介入治疗反应应是首要任务。药物治疗主要基于利尿剂、血管紧张素转换酶抑制剂、强心苷和β受体阻滞剂。儿科心脏病学领域的前瞻性试验较少,但现有数据与成人心力衰竭患者的数据得出了相似的结论。利尿剂是治疗液体潴留患者的重要工具,血管紧张素转换酶抑制剂对心室容量负荷过重的患者有帮助。强心苷仍在使用,但有以利尿剂为主的使用趋势。血管紧张素转换酶抑制剂和β受体阻滞剂已成功用于治疗儿童心力衰竭,但其疗效的数据有限。